Kusama M, Kageshita T, Tsujisaki M, Perosa F, Ferrone S
Cancer Res. 1987 Aug 15;47(16):4312-7.
BALB/c mice were immunized with the murine antihuman high-molecular-weight melanoma-associated antigen monoclonal antibodies (MoAbs) 149.53, 225.28, 653.25, and 763.74. Antiidiotypic antibodies could be detected in bleedings obtained 3 days following the first booster, increased in titer in bleedings obtained following the second booster, and persisted at high level in bleedings obtained 38 days following the second booster. Cross-blocking studies with a panel of anti-melanoma-associated antigen, anti-HLA Class I, and anti-HLA Class II monoclonal antibodies showed that the antisera recognize private idiotypes. The latter are located within the antigen combining site, since antiidiotypic antisera specifically inhibited the binding of the corresponding immunizing anti-human high-molecular-weight melanoma-associated antigen monoclonal antibody to cultured human melanoma cells Colo 38 in a dose-dependent fashion. The spectrotype of the anti-MoAb 149.53 antiserum comprises eight major components in the range of pH 6.2 to 7.0; those of the anti-MoAb 225.28 antiserum and of the anti-MoAb 653.25 antiserum, two major components in the ranges of pH 6.4 to 6.6 and 6.5 to 6.7, respectively; and that of the anti-MoAb 763.74 antiserum, three major components in the range of pH 6.2 to 6.4.
用鼠抗人高分子量黑色素瘤相关抗原单克隆抗体(MoAbs)149.53、225.28、653.25和763.74对BALB/c小鼠进行免疫。在首次加强免疫后3天采集的血液中可检测到抗独特型抗体,在第二次加强免疫后采集的血液中抗体滴度升高,并且在第二次加强免疫后38天采集的血液中抗体滴度维持在高水平。用一组抗黑色素瘤相关抗原、抗HLA I类和抗HLA II类单克隆抗体进行的交叉阻断研究表明,抗血清识别的是独特型。后者位于抗原结合位点内,因为抗独特型抗血清能以剂量依赖的方式特异性抑制相应的免疫用抗人高分子量黑色素瘤相关抗原单克隆抗体与培养的人黑色素瘤细胞Colo 38的结合。抗MoAb 149.53抗血清的光谱型在pH 6.2至7.0范围内包含八个主要成分;抗MoAb 225.28抗血清和抗MoAb 653.25抗血清的光谱型分别在pH 6.4至6.6和6.5至6.7范围内包含两个主要成分;抗MoAb 763.74抗血清的光谱型在pH 6.2至6.4范围内包含三个主要成分。